Matthew Shawn Morris - Sep 21, 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role: Chief Executive Officer, Director
Signature: /s/ Thomas Bartrum, as attorney-in-fact
Stock symbol: PRVA
Transactions as of: Sep 21, 2022
Transactions value $: -$406,794
Form type: 4
Date filed: 9/23/2022, 04:16 PM
Previous filing: Sep 8, 2022
Next filing: Oct 5, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRVA	Common Stock, $0.01 par value per share	Options Exercise	$12K	+5.99K	+4.92%	$2.00	128K	Sep 21, 2022	Direct
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	-$202K	-5.43K	-4.25%	$37.27	122K	Sep 21, 2022	Direct	F1, F2
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	-$21K	-557	-0.46%	$37.63	122K	Sep 21, 2022	Direct	F1, F3
transaction	PRVA	Common Stock, $0.01 par value per share	Options Exercise	$12K	+5.99K	+4.92%	$2.00	128K	Sep 22, 2022	Direct
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	-$171K	-4.96K	-3.88%	$34.49	123K	Sep 22, 2022	Direct	F1, F4
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	-$29.3K	-830	-0.68%	$35.34	122K	Sep 22, 2022	Direct	F1, F5
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	-$7.24K	-200	-0.16%	$36.21	122K	Sep 22, 2022	Direct	F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRVA	Stock Option (Right to Purchase)	Options Exercise	$0	-5.99K	-0.13%	$0.00	4.66M	Sep 21, 2022	Common Stock	5.99K	$2.00	Direct	F7
transaction	PRVA	Stock Option (Right to Purchase)	Options Exercise	$0	-5.99K	-0.13%	$0.00	4.65M	Sep 22, 2022	Common Stock	5.99K	$2.00	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.56 to $37.54 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.57 to $37.68 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.01 to $35.00 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F5	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.01 to $35.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F6	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.07 to $36.33 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F7	Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 3,773,347 of the stock options were fully vested and exercisable. 890,090 of the stock options vest on October 29, 2022.